Delivery Order SPE2DE21D0005-SPE2D625F79CM

Award Date 2/14/25
Potential Completion Date 2/20/25
Potential Value $5.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
The U.S. Department of Defense's Medical Supply Chain (Defense Logistics Agency Troop Support Medical) has awarded Organogenesis Inc. a $8,500.00 fixed-price delivery order contract (SPE2DE21D0005|SPE2D624F9CS2) for the supply of PURAPLY AM XT 4.91x4.91 medical products. This delivery order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials. Organogenesis is...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,500.00 fixed-price delivery order is for the procurement of medical supplies, specifically PURAPLY AM XT 4.91X4.91 wound dressings. The contract has a period of performance through July 23, 2024. Organogenesis is a long-standing federal contractor that specializes in the development and manufacture of advanced wound care and...
The Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract to provide PURAPLY AM (2x2) 4 sq cm wound dressings. This order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials that runs through May 2026. Organogenesis is also a preeminent supplier of...
The Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order to Organogenesis Inc., a leading regenerative medicine company, for the supply of PURAPLY AM wound dressings. The delivery order has a potential value of $1,118.88 and a completion date of February 26, 2024. Organogenesis Inc. has previously been awarded several Indefinite Delivery Vehicles (IDVs) by the Department of Veterans Affairs (VA) and the Defense Logistics Agency to provide a range of regenerative...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care and surgical biologics products. The contract, valued at $8,150.00, is for the delivery of PURAPLY MZ 500MG, a wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract...
The U.S. government has awarded a $2,200.00 fixed-price delivery order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of PURAPLY AM XT 4.91x4.91 medical products. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not utilize a set-aside designation. Organogenesis Inc. is an experienced federal contractor, supplying a wide range of wound care and surgical biologics to the Department of...
This is a $8,800.00 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a manufacturer of regenerative medicine products. The contract is for the delivery of PURAPLY AM XT wound care dressings and has a completion date of June 25, 2024. Organogenesis Inc. is a leading provider of advanced wound care and surgical biologics to the federal government, particularly the Department of Defense (DoD) and Department of Veterans...
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, which does not have a set-aside designation, is a Delivery Order for PURAPLY AM XT 4.91X4.91 medical supplies. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, particularly the Department of...
This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F79CM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $5,100.00, is for the supply of PURAPLY AM XT 4.91X4.91 medical products. This is not a set-aside contract, indicating Organogenesis competed as a standard commercial vendor. The contract is a fixed-price with economic price adjustment type, with a period of performance through February 2025. Organogenesis maintains several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, including a $25 million single-award IDC for Surgical Implant Next Generation products, a $30 million multiple-award Federal Supply Schedule contract, and a $49.5 million multiple-award IDC for wound care dressings and medical supplies. These contract vehicles enable Organogenesis to provide a comprehensive range of regenerative medicine products to support medical treatments across military and veteran healthcare programs.

Generated 5/16/25, 11:42 AM